Catherine Stehman-Breen - 29 Jul 2021 Form 3 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Director
Signature
/s/ Leone Patterson Attorney-in-Fact for Catherine Stehman-Breen
Issuer symbol
TNYA
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3
Filing time
29 Jul 2021, 19:36:25 UTC
Previous filing
11 Jun 2021
Next filing
06 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNYA Common Stock 8,125 29 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNYA Stock Option (Right to Buy) 29 Jul 2021 Common Stock 21,875 $2.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option granted on June 17, 2020 became vested and exercisable as of July 17, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.

Remarks:

Date set forth above represents the effective date of the Issuer's initial public offering